Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2018; 28 (3): 252-253
in English | IMEMR | ID: emr-170962
2.
IJEHSR-International Journal of Endorsing Health Science Research. 2014; 2 (1): 11-15
in English | IMEMR | ID: emr-152015

ABSTRACT

Renal transplantation represents the best available replacement treatment for patients with end stage renal disease patients than performing dialysis, and living donor transplantation has been shown to offer better graft survival than cadaver donor renal transplantation. It was demonstrated that kidneys from living, unrelated donors succeed as well as kidneys obtained from brothers and sisters who share half of the tissue matching antigens with kidney recipients. The study was carried out at department of Angiography, Sindh Institute of Urology and Transplantation [SIUT] from January 2009 to September 2011. A total of 30 patients were included in the study. Informed consent was taken from all patients. Result demonstrates a total of 115 renal arteries in 60 kidneys of donors were depicted at CT angiography [CTA]. Only 57 of kidneys showed more than one or multiple arteries, 52 of these had two renal arteries, and 6 had three renal arteries

3.
IJEHSR-International Journal of Endorsing Health Science Research. 2013; 1 (2): 80-83
in English | IMEMR | ID: emr-133188

ABSTRACT

TACE is the combination of two procedures, an infusion of the mixture of chemotherapeutic agents [e.g. doxorubicin, cysplatin, or mytomycin C] and hepatic artery embolization in which particles such as polyvinyl alcohol or gelfoam, are injected simultaneously into selected branches of the hepatic artery supplying the tumor. Hepatocellular carcinoma is rarely seen before the age of 40 years and reaches a peak at around 70 years of age. Owing to its multicentricity, large tumor size and pre-existing cirrhosis most of these tumors were deemed unrespectable at the time of diagnosis. The purpose of this study was to evaluate the tumor size, site and number of lesions that is acquired on hepatic angiogram during TACE of the liver, and compare it with the information provided by pre-interventional contrast enhanced CT images as there is a possibility that CT may not show smaller lesions. This study was carried out in the Department of Angiography, Sindh Institute of Urology and Transplantation [SIUT] from May to October 2011. A total of 30 patients was included in the study. All individuals underwent pre-procedural imaging with contrast material, enhanced CT angiography or MR to ensure that the disease was liver-dominant and to visualize the blood vessels of the liver. This study included 30 patients age ranges 40-80 years, 22 of whom were males and 8 of them were females. HCC had been diagnosed in all patients. Each patient underwent selective Hepatic Chemoembolization in either the right, left or in both lobes.. In comparison to CT, the hepatic angiogram showed 14[46.6%]patients having single lesion, 7[23.3%] were having double lesions and 9 [30%] were having multiple lesions. So the overall sensitivity of hepatic angiogram in the detecting number of lesions is 75% - 80%. The size of 3cm were found in 7[21%] patients and HCC >4cm was found in 15[44.4%] patients.The size of the HCC which we found in most of the patients during our study is >4cm.

SELECTION OF CITATIONS
SEARCH DETAIL